1. Significant Changes in the Levels of Secreted Cytokines in Brains of Experimental Antiphospholipid Syndrome Mice.
- Author
-
Menachem, Assaf, Chapman, Joab, and Katzav, Aviva
- Subjects
- *
THERAPEUTIC use of cytokines , *LYMPHOCYTES , *B cells , *ANALYSIS of variance , *ANIMAL experimentation , *ANTIPHOSPHOLIPID syndrome , *CYTOKINES , *ENZYME-linked immunosorbent assay , *MICE , *RESEARCH funding , *STATISTICS , *T-test (Statistics) , *DATA analysis , *DATA analysis software , *PHYSIOLOGY - Abstract
Antiphospholipid syndrome (APS) is characterized by thromboses and neuropsychiatric manifestations possibly linked to brain inflammation. In order to examine the levels of proinflammatory and anti-inflammatory cytokines in experimental APS (eAPS) mice brains, we measured the levels of TNF-α, IFN-γ, and IL-10 in brain homogenates (cytosolic fractions) and in brain slices (secreted level) at 6, 15, and 24 weeks after immunization. We induced eAPS by immunization of Balb/c mice with β2-glycoprotein I (β2GPI), the major autoantigen in the disease and controls with adjuvant alone. We found increased levels of secreted TNF-α in eAPS mice for the entire experiment period. Cytosolic and secreted IL-10 and IFN-γ levels in eAPS mice were lower at 6 and 15 weeks and higher at 24 weeks after immunization. The results suggest that brain disease in APS is associated with significant and complex changes in proinflammatory and anti-inflammatory cytokines. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF